Adult incontinence products are reimbursed in Latvia for a set list of diagnosed conditions. Patients diagnosed with these conditions are eligible to a 50% reimbursement from the state for up to three units of adult incontinence.
The state reimbursement system has been strongly criticised as it overlooks many conditions requiring adult incontinence while it is also generally deemed as insufficient. It is estimated that over 150,000 patients require adult incontinence, while only approximately one in every 10 are eligible for support.
A key factor in Rx/reimbursement adult incontinence is eligibility for state support, which requires each eligible product to be approved and included on a list of medical devices. This requires significant resources on behalf of the manufacturer or distributor and places a significant barrier to entry for newcomers, with the market still being relatively small.
You have no recently viewed reports.
Why not browse through our Featured or Trending Reports to see what we have to offer?
Files are delivered directly into your account within a few minutes of purchase.
Discover the latest market trends and uncover sources of future market growth for the Rx/Reimbursement adult incontinence industry in Latvia with research from Euromonitor's team of in-country analysts.
Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.
If you're in the Rx/Reimbursement adult incontinence industry in Latvia, our research will save you time and money while empowering you to make informed, profitable decisions.
The Rx/Reimbursement adult incontinence in Latvia market research report includes:
Our market research reports answer questions such as:
This industry report originates from Passport, our